Pharmacokinetics and Pharmacodynamics PK & PD Services

Pharmacokinetics & Pharmacodynamics

At GCP ClinPlus, our Clinical Pharmacology team provides comprehensive support throughout the research process, including dose prediction, data analysis, and other quantitative pharmacology and clinical pharmacology services. We are responsible for developing pharmacokinetic-related strategy protocols for Phase I clinical trials and bioequivalence (BE) studies, preparing clinical pharmacology sections for regulatory submissions, and establishing quantitative pharmacology models for preclinical through Phase I–III clinical trials, along with report writing. With support for over 500 PK projects completed, we leverage solid expertise and a responsible work ethic to ensure the efficacy and safety of investigational drugs in humans.

Contact

Why Choose Us

Experienced and Expert Team:

Our team has supported over 500 PK projects, accumulating extensive and solid practical experience in clinical and quantitative pharmacology, enabling rapid response and resolution of complex issues.

End-to-End Support:

From early exploration to regulatory submission, we provide full-scope quantitative pharmacology support spanning preclinical to Phase III clinical trials, including protocol design, model development, data analysis, and dose prediction.

Expert Regulatory Submission Support:

We are well-versed in the requirements for global regulatory documents (e.g., IND, NDA) and can efficiently prepare clinical pharmacology sections that meet regulatory expectations, enhancing submission success.

Model-Informed Development Strategies:

We utilize advanced methods such as modeling and simulation and exposure-response analysis to provide scientific support for key decisions (e.g., dose selection, trial design), reducing development uncertainty.

Our PK & PD Key Services

Our PK & PD Services Include

Developing pharmacokinetic-related strategy protocols for Phase I clinical trials and BE studies.
Establishing models and writing reports for preclinical through Phase I–III clinical trials.
Providing comprehensive quantitative and clinical pharmacology support throughout the research process, including dose prediction and data analysis.
Preparing and writing clinical pharmacology content for regulatory submissions (e.g., IND, NDA).
Conducting pharmacokinetic data statistics and report writing.

Benefits of Partnering With Us

Enhanced R&D Efficiency and Quality

Through early involvement and data-driven insights throughout the process, we assist in optimizing trial design, reducing later-stage rework, and saving time and costs.

Accelerated Regulatory Submission Process:

Leveraging our understanding of review requirements from agencies like NMPA and FDA, we prepare high-quality clinical pharmacology documents to expedite the review process.

Science-Driven Key Decisions:

Using quantitative pharmacology models and simulations, we provide evidence for core issues such as dose selection and dosing regimens, improving clinical trial success rates.

Full Compliance and Controllable Risk:

We ensure the research process and submission documents comply with global GCP and relevant guidelines, enhancing study credibility and regulatory confidence.

